Skip to content

Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors

Effect of Cancer Treatment on Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06587477
Enrollment
200
Registered
2024-09-19
Start date
2023-01-16
Completion date
2028-06-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Treatment-Related, Late Effect, Semen Analysis

Keywords

cancer treatment, testicular function, semen quality, cancer survivors

Brief summary

Cancer treatment can affect the testicular function, including sperm and hormonal functions. The aim of this study is to assess the testicular function and semen quality in young men who recover from childhood and adolescent cancer in Hong Kong. This can provide more information for pre-treatment counselling as well as improve post treatment survivorship care. The testicular function will be compared to aged-matched controls from men attending the Family Planning Association for premarital check-up.

Detailed description

This is a cohort observational study. The target population for the trial will be men who have received chemotherapy and/ or radiotherapy for cancer diagnosed when they were \< 18 years old, currently \> 18 years old to 50 years old and cancer in remission for at least 2 years. The testicular function, including sperm and hormonal functions, will be compared with aged-matched controls from men attending the Family Planning Association for premarital check-up.

Interventions

Blood for FSH, LH, testosterone

Semen analysis

OTHERQuestionnaire

The European Male Ageing Study (EMAS) questionnaire

Sponsors

Queen Mary Hospital, Hong Kong
CollaboratorOTHER
Prince of Wales Hospital, Shatin, Hong Kong
CollaboratorOTHER
Hong Kong Children's Hospital
CollaboratorOTHER
The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Men who have received chemotherapy and/ or radiotherapy for cancer diagnosed when they were \< 18 years old. * \> 18 years old to 50 years old * Cancer in remission for at least 2 years

Exclusion criteria

* Unable to ejaculate by masturbation to provide semen samples * Cryptorchidism, testicular cancer, history of vasectomy * On testosterone replacement therapy * Refusal to join the study

Design outcomes

Primary

MeasureTime frameDescription
Sperm concentrationup to 3 monthsSperm concentration

Secondary

MeasureTime frameDescription
Semen parametersup to 3 monthsBased on the WHO criteria

Other

MeasureTime frameDescription
Testicular volumeup to 3 monthsMeasured with the Prader orchidometer
Hormonal profileup to 3 monthsSerum level of testosterone

Countries

China

Contacts

Primary ContactJennifer Ko
jenko@hku.hk22554647

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026